Amyloid Fibrils: Formation, Polymorphism, and Inhibition.

Amyloid fibrils with cross-β spine basic architectures are prevalent and stable forms of peptides and proteins. Recent research has provided significant contributions to our understanding of the mechanisms of fibril formation and to the surprising diversity and persistence of structural polymorphism in amyloid fibrils. There have also been successful demonstrations of how molecules can be engineered to inhibit unwanted amyloid formation by different mechanisms. Future research in these areas will include investigations of mechanisms for primary nucleation and the structure of oligomeric intermediates, the general role of secondary nucleation events (autocatalysis), elucidation of the mechanisms and implications of preservation of structural morphology in amyloid propagation, and research into the largely unexplored phenomenon of cross-seeding, by which amyloid fibrils of one species induce the formation of amyloid by another species.

[1]  Yves F Dufrêne,et al.  Antiparallel beta-sheet: a signature structure of the oligomeric amyloid beta-peptide. , 2009, The Biochemical journal.

[2]  C. Dobson,et al.  A clear view of polymorphism, twist, and chirality in amyloid fibril formation. , 2013, ACS Nano.

[3]  B. Strooper,et al.  The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes , 2012, Nature Neuroscience.

[4]  Nikolaus Grigorieff,et al.  Recent progress in understanding Alzheimer's β-amyloid structures. , 2011, Trends in biochemical sciences.

[5]  Robert A. Grothe,et al.  Structure of the cross-β spine of amyloid-like fibrils , 2005, Nature.

[6]  D. Teplow,et al.  Amyloid β-Protein Assembly and Alzheimer Disease* , 2009, Journal of Biological Chemistry.

[7]  T. Härd,et al.  Amyloid-β Protofibrils: Size, Morphology and Synaptotoxicity of an Engineered Mimic , 2013, PloS one.

[8]  C. Dobson,et al.  Single point mutations induce a switch in the molecular mechanism of the aggregation of the Alzheimer's disease associated Aβ42 peptide. , 2014, ACS chemical biology.

[9]  Elena Orlova,et al.  Cryo‐electron microscopy structure of an SH3 amyloid fibril and model of the molecular packing , 1999, The EMBO journal.

[10]  S. Hornemann,et al.  The amyloid-Congo red interface at atomic resolution. , 2011, Angewandte Chemie.

[11]  A. Wegner,et al.  Fragmentation of actin filaments. , 1982, Biochemistry.

[12]  C. Dobson Protein misfolding, evolution and disease. , 1999, Trends in biochemical sciences.

[13]  Andrea Caporale,et al.  Dissecting the Role of Single Regions of an IAPP Mimic and IAPP in Inhibition of Aβ40 Amyloid Formation and Cytotoxicity , 2011, Chembiochem : a European journal of chemical biology.

[14]  J. Kelly,et al.  Prevention of Transthyretin Amyloid Disease by Changing Protein Misfolding Energetics , 2003, Science.

[15]  Mathias Jucker,et al.  The Amyloid State of Proteins in Human Diseases , 2012, Cell.

[16]  K. Sciarretta,et al.  Peptide-based inhibitors of amyloid assembly. , 2006, Methods in enzymology.

[17]  F. Ferrone,et al.  Kinetics of nucleation-controlled polymerization. A perturbation treatment for use with a secondary pathway. , 1984, Biophysical journal.

[18]  J. Weissman,et al.  Amyloid structure: conformational diversity and consequences. , 2011, Annual review of biochemistry.

[19]  Michele Vendruscolo,et al.  Role of Intermolecular Forces in Defining Material Properties of Protein Nanofibrils , 2007, Science.

[20]  P. Lansbury,et al.  Amyloid fibril formation requires a chemically discriminating nucleation event: studies of an amyloidogenic sequence from the bacterial protein OsmB. , 1992, Biochemistry.

[21]  F. Heppner,et al.  Evidence for age-dependent in vivo conformational rearrangement within Aβ amyloid deposits. , 2013, ACS chemical biology.

[22]  C. Dobson,et al.  Role of elongation and secondary pathways in S6 amyloid fibril growth. , 2012, Biophysical journal.

[23]  Charles D. Schwieters,et al.  Molecular Structure of β-Amyloid Fibrils in Alzheimer’s Disease Brain Tissue , 2013, Cell.

[24]  J. Hofrichter,et al.  Kinetics of sickle hemoglobin polymerization. II. A double nucleation mechanism. , 1985, Journal of molecular biology.

[25]  Michele Vendruscolo,et al.  Nucleated polymerization with secondary pathways. II. Determination of self-consistent solutions to growth processes described by non-linear master equations. , 2011, The Journal of chemical physics.

[26]  Ronald Wetzel,et al.  Seeding Specificity in Amyloid Growth Induced by Heterologous Fibrils* , 2004, Journal of Biological Chemistry.

[27]  D. Frenkel,et al.  Onset of heterogeneous crystal nucleation in colloidal suspensions , 2004, Nature.

[28]  H. Nieznańska,et al.  Cross-seeding of fibrils from two types of insulin induces new amyloid strains. , 2012, Biochemistry.

[29]  Sara Linse,et al.  Quantification of the concentration of Aβ42 propagons during the lag phase by an amyloid chain reaction assay. , 2014, Journal of the American Chemical Society.

[30]  R. Tycko,et al.  Evidence for novel beta-sheet structures in Iowa mutant beta-amyloid fibrils. , 2009, Biochemistry.

[31]  Richard D. Leapman,et al.  Self-Propagating, Molecular-Level Polymorphism in Alzheimer's ß-Amyloid Fibrils , 2005, Science.

[32]  Ruth Nussinov,et al.  Selective molecular recognition in amyloid growth and transmission and cross-species barriers. , 2012, Journal of molecular biology.

[33]  Michele Vendruscolo,et al.  Systematic In Vivo Analysis of the Intrinsic Determinants of Amyloid β Pathogenicity , 2007, PLoS biology.

[34]  T. Härd,et al.  Inhibition of amyloid formation. , 2012, Journal of molecular biology.

[35]  C. Dobson,et al.  Sequestration of the Aβ Peptide Prevents Toxicity and Promotes Degradation In Vivo , 2010, PLoS biology.

[36]  Michele Vendruscolo,et al.  Proliferation of amyloid-β42 aggregates occurs through a secondary nucleation mechanism , 2013, Proceedings of the National Academy of Sciences.

[37]  C. Dobson,et al.  Stabilization of neurotoxic Alzheimer amyloid-β oligomers by protein engineering , 2010, Proceedings of the National Academy of Sciences.

[38]  Michele Vendruscolo,et al.  Atomic structure and hierarchical assembly of a cross-β amyloid fibril , 2013, Proceedings of the National Academy of Sciences.

[39]  David Eisenberg,et al.  Atomic View of a Toxic Amyloid Small Oligomer , 2012, Science.

[40]  L. Tjernberg,et al.  Arrest of -Amyloid Fibril Formation by a Pentapeptide Ligand (*) , 1996, The Journal of Biological Chemistry.

[41]  L. Lannfelt,et al.  Imaging distinct conformational states of amyloid-beta fibrils in Alzheimer's disease using novel luminescent probes. , 2007, ACS chemical biology.

[42]  L. Kiessling,et al.  Structure-function relationships for inhibitors of beta-amyloid toxicity containing the recognition sequence KLVFF. , 2001, Biochemistry.

[43]  Sara Linse,et al.  Amyloid β-protein aggregation produces highly reproducible kinetic data and occurs by a two-phase process. , 2010, ACS chemical neuroscience.

[44]  Hugo M. Botelho,et al.  S100A6 Amyloid Fibril Formation Is Calcium-modulated and Enhances Superoxide Dismutase-1 (SOD1) Aggregation* , 2012, The Journal of Biological Chemistry.

[45]  R. Tycko,et al.  Polymorph-specific kinetics and thermodynamics of β-amyloid fibril growth. , 2013, Journal of the American Chemical Society.

[46]  E. Goormaghtigh,et al.  ATR-FTIR: a "rejuvenated" tool to investigate amyloid proteins. , 2013, Biochimica et biophysica acta.

[47]  S. Radford,et al.  Conformational Conversion during Amyloid Formation at Atomic Resolution , 2011, Molecular cell.

[48]  John Collinge,et al.  A General Model of Prion Strains and Their Pathogenicity , 2007, Science.

[49]  Tuomas P. J. Knowles,et al.  An Analytical Solution to the Kinetics of Breakable Filament Assembly , 2009, Science.

[50]  G. Glenner,et al.  X-RAY DIFFRACTION STUDIES ON AMYLOID FILAMENTS , 1968, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[51]  Steven M. Johnson,et al.  Structure-based design of kinetic stabilizers that ameliorate the transthyretin amyloidoses. , 2010, Current opinion in structural biology.

[52]  A. Miranker,et al.  Fiber-dependent amyloid formation as catalysis of an existing reaction pathway , 2007, Proceedings of the National Academy of Sciences.

[53]  Michele Vendruscolo,et al.  Nucleated polymerization with secondary pathways. I. Time evolution of the principal moments. , 2011, The Journal of chemical physics.

[54]  I. Graef,et al.  AG10 inhibits amyloidogenesis and cellular toxicity of the familial amyloid cardiomyopathy-associated V122I transthyretin , 2013, Proceedings of the National Academy of Sciences.

[55]  S. Lindström,et al.  Selection and characterization of Affibody ligands binding to Alzheimer amyloid β peptides , 2007 .

[56]  J. Kelly,et al.  Partial denaturation of transthyretin is sufficient for amyloid fibril formation in vitro. , 1992, Biochemistry.

[57]  M. Benson,et al.  Amyloid fibril protein nomenclature: 2010 recommendations from the nomenclature committee of the International Society of Amyloidosis , 2010, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[58]  T. Härd,et al.  Stabilization of a β-hairpin in monomeric Alzheimer's amyloid-β peptide inhibits amyloid formation , 2008, Proceedings of the National Academy of Sciences.

[59]  Jason T. Stevens,et al.  Structure-based design of non-natural amino-acid inhibitors of amyloid fibril formation , 2011, Nature.

[60]  T. Härd Protein engineering to stabilize soluble amyloid β‐protein aggregates for structural and functional studies , 2011, The FEBS journal.

[61]  Jonathan S. Weissman,et al.  The physical basis of how prion conformations determine strain phenotypes , 2006, Nature.

[62]  P. Westermark,et al.  Protein fibrils in nature can enhance amyloid protein A amyloidosis in mice: Cross-seeding as a disease mechanism , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[63]  C. Dobson,et al.  Formation of mixed fibrils demonstrates the generic nature and potential utility of amyloid nanostructures , 2000 .

[64]  Michele Vendruscolo,et al.  Metastability of native proteins and the phenomenon of amyloid formation. , 2011, Journal of the American Chemical Society.